P/E ratio for PolarityTE (PTE)
P/E ratio as of May 2024 (TTM): -0.1106
According to PolarityTE's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.11055. At the end of 2022 the company had a P/E ratio of -0.5789.
P/E ratio history for PolarityTE from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.5789 | -51.47% |
| 2021 | -1.19 | 94.74% |
| 2020 | -0.6126 | -11.11% |
| 2019 | -0.6892 | -76.24% |
| 2018 | -2.90 | 216.98% |
| 2017 | -0.9153 | 37.15% |
| 2016 | -0.6673 | -56.48% |
| 2015 | -1.53 | 194.99% |
| 2014 | -0.5198 | -74.07% |
| 2013 | -2.00 | -125.32% |
| 2012 | 7.92 | -55.47% |
| 2011 | 17.8 | -187.43% |
| 2010 | -20.3 | 378.43% |
| 2009 | -4.25 | -191.07% |
| 2008 | 4.67 | -162.22% |
| 2007 | -7.50 | 42.86% |
| 2006 | -5.25 | 968.42% |
| 2005 | -0.4914 | -93.7% |
| 2004 | -7.80 | 342.98% |
| 2003 | -1.76 | -41.33% |
| 2002 | -3.00 | 1034.37% |
| 2001 | -0.2645 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -4.28 | 3,771.39% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.